(R,E)-N-(4-(3-((5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl)amino)azepane-1-carbonyl)phenyl)-4-(dimethylamino)but-2-enamide

ID: ALA4870659

PubChem CID: 164625238

Max Phase: Preclinical

Molecular Formula: C31H34ClN7O2

Molecular Weight: 572.11

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)C/C=C/C(=O)Nc1ccc(C(=O)N2CCCC[C@@H](Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)C2)cc1

Standard InChI:  InChI=1S/C31H34ClN7O2/c1-38(2)16-7-11-28(40)35-22-14-12-21(13-15-22)30(41)39-17-6-5-8-23(20-39)36-31-34-19-26(32)29(37-31)25-18-33-27-10-4-3-9-24(25)27/h3-4,7,9-15,18-19,23,33H,5-6,8,16-17,20H2,1-2H3,(H,35,40)(H,34,36,37)/b11-7+/t23-/m1/s1

Standard InChI Key:  NBELKEMVBFHPAA-GULCCPCXSA-N

Molfile:  

 
     RDKit          2D

 41 45  0  0  0  0  0  0  0  0999 V2000
   35.5279   -8.3643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5969   -9.1888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.3442   -9.5397    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.0231   -9.0671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9498   -8.2397    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.2022   -7.8927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7705   -9.4163    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.4468   -8.9437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9225   -9.6630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1157  -10.7267    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.9054  -10.4878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6446  -10.0492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1418   -9.3959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8242   -8.6408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0100   -8.5379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5141   -9.1962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8343   -9.9487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7809   -8.0140    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   39.9112   -8.7009    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.6249   -9.1149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.6230   -9.9400    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.3403   -8.7040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0510   -9.1189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.7659   -8.7086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.7682   -7.8827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0496   -7.4687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.3376   -7.8813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.4830   -7.4707    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   44.1973   -7.8840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.9122   -7.4720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.1966   -8.7090    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   45.6263   -7.8852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.3412   -7.4732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   47.0553   -7.8865    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   47.7703   -7.4746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   47.0546   -8.7116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.3579   -7.3188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5198   -7.4719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1482   -8.1881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.9742   -7.8772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2002   -9.1802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  8  7  1  6
  9 13  1  0
 12 10  1  0
 10 11  1  0
 11  9  2  0
  2  9  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
  1 18  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 25 28  1  0
 28 29  1  0
 29 30  1  0
 29 31  2  0
 30 32  2  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 34 36  1  0
 37 38  1  0
 38 39  1  0
 37 40  1  0
 19 41  1  0
 41  8  1  0
  8 39  1  0
 40 19  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4870659

    ---

Associated Targets(Human)

CDK2 Tchem CDK2/Cyclin A2 (2260 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNH Tbio Cyclin-dependent kinase 7/ cyclin H (714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNT1 Tchem CDK9/cyclin T1 (2643 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNK Tbio CDK12/Cyclin K (892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK13 Tchem Cyclin-dependent kinase 13/Cyclin-K (53 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 572.11Molecular Weight (Monoisotopic): 571.2463AlogP: 5.44#Rotatable Bonds: 8
Polar Surface Area: 106.25Molecular Species: BASEHBA: 6HBD: 3
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.75CX Basic pKa: 8.81CX LogP: 4.76CX LogD: 3.34
Aromatic Rings: 4Heavy Atoms: 41QED Weighted: 0.24Np Likeness Score: -1.21

References

1. Jiang B, Jiang J, Kaltheuner IH, Iniguez AB, Anand K, Ferguson FM, Ficarro SB, Seong BKA, Greifenberg AK, Dust S, Kwiatkowski NP, Marto JA, Stegmaier K, Zhang T, Geyer M, Gray NS..  (2021)  Structure-activity relationship study of THZ531 derivatives enables the discovery of BSJ-01-175 as a dual CDK12/13 covalent inhibitor with efficacy in Ewing sarcoma.,  221  [PMID:33945934] [10.1016/j.ejmech.2021.113481]

Source